The Role of Intracranial Atherosclerosis in the Development of Alzheimer's Disease
The Role of Intracranial Atherosclerosis in the Development of Alzheimer's Disease
批准号:
10414297
负责人:
BRUCE A WASSERMAN
金额:
$72.27万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2024-05-31
关键词:
3-DimensionalAddressAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAmyloid beta-ProteinAncillary StudyArterial Fatty StreakAtherosclerosisAtherosclerosis Risk in CommunitiesAutopsyBloodBlood CirculationBlood VesselsBlood flowBrainCardiovascular DiseasesCardiovascular systemCharacteristicsCognitiveCommunitiesComplexCross-Sectional StudiesDataDementiaDevelopmentDiseaseDisease ProgressionEconomic BurdenElderlyEndotheliumEnrollmentEtiologyEvaluationFoam CellsFundingGeographic DistributionHealthHeart DiseasesImageImaging TechniquesImpaired cognitionImpairmentInfarctionIntracranial Atherosclerotic DiseaseLeadLesionLinkMagnetic Resonance ImagingMalignant NeoplasmsMeasurementMeasuresMedical Care CostsMethodsMicrovascular DysfunctionModificationNatural HistoryNeurocognitiveNeuronsOutcomeParticipantPathogenesisPathologicPersonsPharmaceutical PreparationsPositioning AttributePredictive FactorPredictive ValuePrevention strategyPreventiveProspective StudiesRiskRisk FactorsRoleSample SizeScanningStenosisTechniquesTestingTherapeuticThickTimeToxic effectTreatment ProtocolsUnited States National Institutes of HealthValidationVisitWhite Matter Hyperintensityabeta accumulationagedbasebrain volumeburden of illnessclinical Diagnosiscognitive developmentcohortdesigneffective therapyfollow-upgender differenceindexingintracranial arterymiddle agemild cognitive impairmentmortalitynovelpreventprospectiveracial differencerecruitrisk stratificationtooltreatment strategyvascular risk factor
中文摘要
理由:痴呆症在美国和世界范围内是一个日益严重的问题。缺乏有效的治疗或
阿尔茨海默病(AD)是导致痴呆症的最常见原因,其预防策略已导致
不断增加的死亡率和飙升的医疗费用。颅内动脉粥样硬化性疾病(ICAD)也高度
在老年人中普遍存在,新的证据表明它可能与AD及其前驱疾病轻度有关
认知障碍(MCI),但缺乏前瞻性验证。我们建议前瞻性地研究
ICAD及其进展在认知功能减退、MCI和痴呆,尤其是AD的发展中的作用。
目的:我们将确定ICAD的存在和MRI测量,包括其进展和风险指数
根据基线ICAD特征,导致认知功能减退、事件MCI和事件痴呆。我们会
确定ICAD是否增加了局部脑体积损失的预测价值,这是AD的已知预测指标。最后,
我们将建立预测ICAD进展的危险因素和斑块特征。
设计/方法:我们将对社区动脉硬化风险(ARIC)研究进行一项辅助研究,
由美国国立卫生研究院资助的心血管队列,最初有大约16,000名参与者,年龄45-,他们已经
自1987年以来一直如此。ARIC神经认知研究(ARIC-NCS),在ARIC最近一次访问中进行
2011-2013年,获得性脑磁共振成像和认知评估,以研究血管的横断面关联
MCI和痴呆的危险因素及脑部MRI改变。MRI还识别和测量了狭窄,对于
ICAD首次使用了一种新的血管壁成像技术。这项技术可以检测动脉粥样硬化
斑块即使不会导致狭窄,也可能是动脉粥样硬化性疾病负担的更好衡量标准。
我们计划在NIH资助的下一次ARIC访问中对1000名参与者进行重复的脑MRI检查,该访问将于
在间隔5-8年测量ICAD进展、脑容量丧失和小血管疾病后的2016年
(Svd),与AD相关的另一个血液流动障碍的原因。重复的认知评估也是
有计划的。我们预计,到本考试开始时,MCI和痴呆症的发病率分别为335例和266例。
然后,我们将评估基线时ICAD与事件认知结果的关联。核磁共振成像将允许
美国对AD(或MCI中的AD类型)进行具体诊断,允许分析其危险因素。此外,我们
将使用后续的MRI数据来测量管腔狭窄和管壁厚度的变化,以确定ICAD
进步。在分析与ICAD的关联时,我们将考虑SVD和血管危险因素。它是
值得注意的是,大面积脑梗塞是痴呆症的罕见原因,也不是本研究的主要重点。
影响:通过我们提议的研究,我们将确定ICAD在发展和
MCI的进展与痴呆,尤其是AD。这将是描述自然历史的第一次研究
ICAD进展及其预测认知结果的能力。这一信息可能会导致预防
目前无法治愈的疾病的治疗方案的策略和风险分层。
英文摘要
Rationale: Dementia is a growing problem in the US and worldwide. The lack of effective treatment or
preventive strategies for Alzheimer’s Disease (AD), the most common cause of dementia, has led to an
increasing mortality rate and soaring medical costs. Intracranial atherosclerotic disease (ICAD) is also highly
prevalent in older adults, and new evidence suggests it may be associated with AD and its precursor, mild
cognitive impairment (MCI), but prospective validation is lacking. We propose to prospectively study the role of
ICAD and its progression in the development of cognitive decline, MCI and dementia, in particular AD.
Aims: We will determine if ICAD presence and measures by MRI, including its progression and a risk index
based on baseline ICAD features, lead to cognitive decline, incident MCI and incident dementia. We will
determine if ICAD adds to the predictive value of regional brain volume loss, a known predictor of AD. Finally,
we will establish risk factors and plaque features that predict progression of ICAD.
Design/Methods: We will conduct an ancillary study to the Atherosclerosis Risk in Communities (ARIC) Study,
an NIH-funded cardiovascular cohort that began with about 16,000 participants, aged 45-64, who have been
followed since 1987. The ARIC Neurocognitive Study (ARIC-NCS), conducted at the most recent ARIC visit in
2011-2013, acquired brain MRIs and cognitive evaluations to study cross-sectional associations of vascular
risk factors and MRI brain changes with MCI and dementia. MRI also identified and measured stenosis and, for
the first time, ICAD using a novel vessel wall imaging technique. This technique detects atherosclerotic
plaques even if they do not result in stenosis and may be a better measure of atherosclerotic disease burden.
We plan to acquire a repeat brain MRI in 1,000 participants at the next NIH-funded ARIC visit that begins in
2016 after a 5-8 year interval to measure ICAD progression, brain volume loss, and small vessel disease
(SVD), another cause of blood flow impairment associated with AD. Repeat cognitive evaluations are also
planned. We expect 335 and 266 incident cases of MCI and dementia, respectively, by the start of this exam.
We will then evaluate the association of ICAD at baseline with incident cognitive outcomes. The MRI will allow
us to make a specific diagnosis of AD (or AD-type in MCI), permitting analysis of its risk factors. In addition, we
will use follow-up MRI data to measure changes in luminal stenosis and vessel wall thickness to identify ICAD
progression. We will account for SVD and vascular risk factors when analyzing associations with ICAD. It is
worth noting that large infarcts are an uncommon cause of dementia and not the primary focus of this study.
Implications: Through our proposed study we will establish the role of ICAD in the development and
progression of MCI and dementia, in particular AD. This will be the first study characterizing the natural history
of ICAD progression and its ability to predict cognitive outcomes. This information could lead to preventive
strategies and risk stratification for treatment protocols in an otherwise currently untreatable disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1161/jaha.123.031832
发表时间:
2023-10-17
期刊:
Journal of the American Heart Association
影响因子:
5.4
作者:
[]
通讯作者:
The Role of Intracranial Atherosclerosis in the Development of Alzheimer's Disease
-
批准号:9216367
-
项目类别:
-
资助金额:$143.38万
-
财政年份:2016
-
负责人:BRUCE A WASSERMAN
-
依托单位:
COMPOSITIONAL ANALYSIS OF PLAQUE ELEMENTS IN CAROTID ATHEROMAS
-
批准号:7378815
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2005
-
负责人:BRUCE A WASSERMAN
-
依托单位:
COMPOSITIONAL ANALYSIS OF PLAQUE ELEMENTS IN CAROTID ATHEROMAS
-
批准号:7200730
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2005
-
负责人:BRUCE A WASSERMAN
-
依托单位:
Compositional Analysis of Plaque Elements in Carotid Atheromas
-
批准号:7044679
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2003
-
负责人:BRUCE A WASSERMAN
-
依托单位:
Contract-Enhanced MRI for Evaluating Carotid Atheroma
-
批准号:6795598
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2002
-
负责人:BRUCE A WASSERMAN
-
依托单位:
Contract-Enhanced MRI for Evaluating Carotid Atheroma
-
批准号:6459874
-
项目类别:
-
资助金额:$43.82万
-
财政年份:2002
-
负责人:BRUCE A WASSERMAN
-
依托单位:
Contract-Enhanced MRI for Evaluating Carotid Atheroma
-
批准号:6667141
-
项目类别:
-
资助金额:$41.22万
-
财政年份:2002
-
负责人:BRUCE A WASSERMAN
-
依托单位:
海外基金